News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
101,022 Results
Type
Article (7219)
Company Profile (43)
Press Release (93753)
Multimedia
Podcasts (17)
Webinars (3)
Section
Business (29168)
Career Advice (148)
Deals (4238)
Drug Delivery (41)
Drug Development (14641)
Employer Resources (12)
FDA (3054)
Job Trends (2168)
News (51698)
Policy (6333)
Tag
Academia (433)
Accelerated approval (13)
Adcomms (7)
Allergies (41)
Alliances (9266)
ALS (32)
Alzheimer's disease (353)
Antibody-drug conjugate (ADC) (102)
Approvals (3027)
Artificial intelligence (113)
Autoimmune disease (39)
Automation (7)
Bankruptcy (20)
Best Places to Work (1822)
BIOSECURE Act (17)
Biosimilars (132)
Biotechnology (31)
Bladder cancer (40)
Brain cancer (12)
Breast cancer (117)
Cancer (955)
Cardiovascular disease (53)
Career advice (130)
Career pathing (5)
CAR-T (50)
CDC (9)
Cell therapy (168)
Cervical cancer (8)
Clinical research (12691)
Collaboration (397)
Compensation (97)
Complete response letters (26)
COVID-19 (613)
CRISPR (12)
C-suite (148)
Cystic fibrosis (16)
Data (1337)
Denatured (6)
Depression (15)
Diabetes (68)
Diagnostics (598)
Digital health (5)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (74)
Drug pricing (40)
Drug shortages (2)
Duchenne muscular dystrophy (77)
Earnings (10855)
Editorial (15)
Employer branding (3)
Employer resources (10)
Events (13052)
Executive appointments (197)
FDA (3812)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (274)
Gene editing (41)
Generative AI (18)
Gene therapy (169)
GLP-1 (150)
Government (1407)
Grass and pollen (1)
Guidances (83)
Healthcare (2027)
HIV (10)
Huntington's disease (13)
IgA nephropathy (15)
Immunology and inflammation (91)
Immuno-oncology (17)
Indications (22)
Infectious disease (684)
Inflammatory bowel disease (68)
Inflation Reduction Act (7)
Influenza (38)
Intellectual property (32)
Interviews (13)
IPO (2013)
IRA (16)
Job creations (400)
Job search strategy (123)
Kidney cancer (4)
Labor market (10)
Layoffs (70)
Leadership (3)
Legal (577)
Liver cancer (13)
Longevity (7)
Lung cancer (150)
Lymphoma (68)
Machine learning (12)
Management (2)
Manufacturing (273)
MASH (30)
Medical device (1201)
Medtech (1210)
Mergers & acquisitions (2410)
Metabolic disorders (171)
Multiple sclerosis (38)
NASH (2)
Neurodegenerative disease (67)
Neuropsychiatric disorders (8)
Neuroscience (560)
NextGen: Class of 2025 (716)
Non-profit (368)
Now hiring (19)
Obesity (62)
Opinion (63)
Ovarian cancer (40)
Pain (20)
Pancreatic cancer (31)
Parkinson's disease (37)
Partnered (9)
Patents (76)
Patient recruitment (79)
Peanut (24)
People (8792)
Pharmaceutical (10)
Pharmacy benefit managers (6)
Phase I (4155)
Phase II (5279)
Phase III (4661)
Pipeline (1060)
Policy (114)
Postmarket research (301)
Preclinical (1646)
Press Release (66)
Prostate cancer (39)
Psychedelics (6)
Radiopharmaceuticals (45)
Rare diseases (183)
Real estate (967)
Recruiting (4)
Regulatory (5573)
Reports (12)
Research institute (401)
Resumes & cover letters (16)
Rett syndrome (6)
RNA editing (2)
RSV (21)
Schizophrenia (26)
Series A (59)
Series B (28)
Service/supplier (3)
Sickle cell disease (19)
Special edition (4)
Spinal muscular atrophy (23)
Sponsored (14)
Startups (605)
State (1)
Stomach cancer (5)
Supply chain (16)
Tariffs (19)
The Weekly (11)
Vaccines (287)
Venture capital (14)
Weight loss (28)
Women's health (3)
Date
Last 7 days (119)
Last 30 days (466)
Last 365 days (6441)
2025 (6389)
2024 (6876)
2023 (7491)
2022 (9482)
2021 (9907)
2020 (8516)
2019 (6046)
2018 (4657)
2017 (5231)
2016 (4718)
2015 (5425)
2014 (3814)
2013 (2968)
2012 (3068)
2011 (3222)
2010 (2655)
Location
Africa (100)
Alabama (18)
Alaska (1)
Arizona (17)
Arkansas (2)
Asia (8347)
Australia (956)
California (2118)
Canada (428)
China (362)
Colorado (46)
Connecticut (95)
Delaware (96)
Europe (15007)
Florida (292)
Georgia (36)
Idaho (14)
Illinois (90)
India (30)
Indiana (58)
Iowa (9)
Japan (90)
Kansas (7)
Kentucky (12)
Louisiana (2)
Maine (22)
Maryland (436)
Massachusetts (1570)
Michigan (33)
Minnesota (75)
Mississippi (4)
Missouri (27)
Montana (5)
Nebraska (1)
Nevada (9)
New Hampshire (3)
New Jersey (740)
New Mexico (4)
New York (618)
North Carolina (294)
North Dakota (9)
Northern California (1005)
Ohio (58)
Oklahoma (12)
Oregon (5)
Pennsylvania (353)
Puerto Rico (2)
Rhode Island (7)
South America (139)
South Carolina (3)
Southern California (881)
Tennessee (7)
Texas (303)
United States (7477)
Utah (39)
Virginia (30)
Washington D.C. (9)
Washington State (163)
West Virginia (1)
Wisconsin (14)
101,022 Results for "cmc biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Solvias to Speak at Festival of Biologics 2025 on Building Robust CMC Assays for Biologic Therapies
April 23, 2025
·
2 min read
Press Releases
Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer
November 20, 2025
·
7 min read
Sponsored
Cracking the Code: Solving Microbial Manufacturing’s Biggest Challenges
Perfecting microbial manufacturing processes means taming its greatest asset: speed. This rapid process for creating biologics also means a race against time, where success hinges on conquering three key challenges: designing a robust microbial strain, optimizing fermentation for industrial scale, and ensuring consistent high-yield product yield.
December 1, 2025
·
6 min read
·
AGC Biologics
Press Releases
ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials
October 31, 2025
·
4 min read
Press Releases
Ajax Therapeutics Appoints David Waller, PhD, as Senior Vice President and Head of CMC
August 20, 2025
·
3 min read
Press Releases
Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)
June 18, 2025
·
3 min read
Press Releases
Sino Biological Wins 2025 Scientist.com’s Supplier Recognition Award
Recognized for Excellence in Drug Discovery Research Services on Global R&D Sourcing Platform in 2025.
December 16, 2025
·
3 min read
Press Releases
Polpharma Biologics and Libbs Farmacêutica Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases
December 10, 2025
·
4 min read
Press Releases
OS Therapies Announces Successful pre-Marketing Authorisation Application Meeting with UK MHRA Regarding the Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
Alignment achieved on all key points surrounding non-clinical, CMC and post-market authorization confirmatory study design Biomarker data advanced as key pre-specified surrogate clinical efficacy endpoint, with pending analysis awaiting alignment with US FDA on biomarker statistical analysis plan to be discussed at upcoming December 11, 2025 FDA Type C Meeting Company reiterates end of January 2026 timeline for MAA submission
December 9, 2025
·
4 min read
Sponsored
Accelerating Timelines and Reducing Cost in Early Clinical Drug Development With ICON’s Accelerated Pharmaceutical Solutions
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced formulation design, real-time dose flexibility, and cutting-edge CMC expertise to transform complexity into clarity. By uniting science, technology, and strategy, biotechs can move faster, smarter, and with confidence—turning obstacles into opportunities for breakthrough success.
December 8, 2025
·
5 min read
·
Arjen Akkerman
1 of 10,103
Next